Icon enjoys 1.4% increase in revenue

Dublin: Irish clinical trials and pharmaceutical services company, Icon has reported a 1.4% increase in 2010 net revenue to $900 million (€652m) and a 10.2% increase in operating profit, for the year, to $92m (€67m).

New business value exceeded the $1 billion mark last year and the Nasdaq-listed company is anticipating 5%-9% revenue growth this year.